E H Herman1, V J Ferrans. Show Affiliations » 1. Division of Drug Research and Testing, Food and Drug, Administration, Washington, D.C. 20204.
Abstract
Entities: Chemical Disease
Mesh: See more » AnimalsCardiomyopathies/chemically inducedCardiomyopathies/pathologyCardiomyopathies/prevention & controlChronic DiseaseDaunorubicin/adverse effectsMaleMyocardium/pathologyMyofibrils/drug effectsMyofibrils/pathologyRabbitsRazoxane/therapeutic useTime FactorsVacuoles/drug effectsVacuoles/pathology
Substances: See more » RazoxaneDaunorubicin
Year: 1990 PMID: 2125530 DOI: 10.1016/0305-7372(90)90040-m
Source DB: PubMed Journal: Cancer Treat Rev ISSN: 0305-7372 Impact factor: 12.111